Hong Kong stocks fluctuate | Kalon Biotherapeutics (06990.HK) up over 6% Asco discloses important lung cancer data sac-TMT overseas will soon enter the commercialization stage.

According to the Wise Wealth Finance APP, Collonbo Technologies Biotechnology (06990.HK) surged by over 6%, as of the time of the report, it increased by 5.33%, at 419.4 Hong Kong dollars, with a turnover of 29.2642 million Hong Kong dollars.